Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $12.37 $15.43 Thursday, 9th May 2024 URGN stock ended at $12.97. This is 2.26% less than the trading day before Wednesday, 8th May 2024. During the day the stock fluctuated 4.81% from a day low at $12.60 to a day high of $13.21.
90 days $12.37 $19.87
52 weeks $8.69 $24.13

Historical UroGen Pharma Ltd prices

Date Open High Low Close Volume
Dec 29, 2017 $38.44 $38.44 $37.21 $37.21 51 668
Dec 28, 2017 $38.50 $38.72 $37.71 $38.25 39 491
Dec 27, 2017 $37.50 $38.50 $37.30 $38.34 135 200
Dec 26, 2017 $38.61 $38.68 $37.19 $37.58 163 753
Dec 22, 2017 $38.41 $38.78 $37.74 $38.77 27 590
Dec 21, 2017 $37.19 $39.50 $37.19 $38.49 133 455
Dec 20, 2017 $38.12 $38.40 $37.64 $37.87 23 174
Dec 19, 2017 $39.60 $39.80 $38.06 $38.53 41 762
Dec 18, 2017 $38.48 $39.93 $38.06 $39.78 191 583
Dec 15, 2017 $37.28 $38.00 $37.11 $37.94 79 927
Dec 14, 2017 $36.85 $37.90 $36.66 $37.10 83 739
Dec 13, 2017 $38.58 $38.58 $36.73 $36.80 137 756
Dec 12, 2017 $37.39 $38.95 $37.39 $38.55 203 358
Dec 11, 2017 $38.95 $39.49 $37.27 $37.71 150 624
Dec 08, 2017 $39.38 $39.38 $38.21 $38.46 33 549
Dec 07, 2017 $37.51 $40.00 $37.51 $39.26 62 237
Dec 06, 2017 $38.03 $38.93 $37.50 $37.55 98 310
Dec 05, 2017 $40.22 $40.77 $37.62 $38.61 109 915
Dec 04, 2017 $40.31 $41.25 $39.72 $40.43 212 279
Dec 01, 2017 $40.15 $40.48 $38.90 $39.65 86 223
Nov 30, 2017 $40.13 $40.60 $40.03 $40.37 187 083
Nov 29, 2017 $40.25 $40.50 $39.50 $40.11 81 780
Nov 28, 2017 $40.95 $41.01 $40.18 $40.43 402 436
Nov 27, 2017 $42.00 $42.59 $40.57 $40.78 164 354
Nov 24, 2017 $40.30 $41.89 $40.11 $40.94 46 326
Click to get the best stock tips daily for free!

About UroGen Pharma Ltd

UroGen Pharma Ltd UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead product candidate is UGN-102, which is in Phase III clinical trials for the treatment of several forms... URGN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT